Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)
Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%
Viatris total assets
Total assets on the balance sheet at the end of each period.
Viatris's total assets was $35.04B at Jun 30, 2026. For fiscal 2025 it was $37.19B, down 10.4% from the year before. The highest annual figure on record is $61.55B in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.19B | -10.4% |
| FY2024 | Dec 31, 2024 | $41.50B | -13.0% |
| FY2023 | Dec 31, 2023 | $47.69B | -4.7% |
| FY2022 | Dec 31, 2022 | $50.02B | -8.8% |
| FY2021 | Dec 31, 2021 | $54.84B | -10.9% |
| FY2020 | Dec 31, 2020 | $61.55B | +96.9% |
| FY2019 | Dec 31, 2019 | $31.26B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $35.04B | -8.8% |
| Q1 FY2026 | Mar 31, 2026 | $36.83B | -4.3% |
| Q4 FY2025 | Dec 31, 2025 | $37.19B | -10.4% |
| Q3 FY2025 | Sep 30, 2025 | $37.92B | -15.3% |
| Q2 FY2025 | Jun 30, 2025 | $38.41B | -15.3% |
| Q1 FY2025 | Mar 31, 2025 | $38.47B | -18.7% |
| Q4 FY2024 | Dec 31, 2024 | $41.50B | -13.0% |
| Q3 FY2024 | Sep 30, 2024 | $44.75B | -8.2% |
| Q2 FY2024 | Jun 30, 2024 | $45.33B | -6.9% |
| Q1 FY2024 | Mar 31, 2024 | $47.34B | -3.9% |
| Q4 FY2023 | Dec 31, 2023 | $47.69B | -4.7% |
| Q3 FY2023 | Sep 30, 2023 | $48.74B | +0.2% |
| Q2 FY2023 | Jun 30, 2023 | $48.70B | -4.8% |
| Q1 FY2023 | Mar 31, 2023 | $49.29B | -7.8% |
| Q4 FY2022 | Dec 31, 2022 | $50.02B | -8.8% |
| Q3 FY2022 | Sep 30, 2022 | $48.66B | -13.2% |
| Q2 FY2022 | Jun 30, 2022 | $51.13B | -11.8% |
| Q1 FY2022 | Mar 31, 2022 | $53.47B | -9.3% |
| Q4 FY2021 | Dec 31, 2021 | $54.84B | -10.9% |
| Q3 FY2021 | Sep 30, 2021 | $56.07B | +391.3% |
| Q2 FY2021 | Jun 30, 2021 | $57.98B | +408.1% |
| Q1 FY2021 | Mar 31, 2021 | $58.98B | – |
| Q4 FY2020 | Dec 31, 2020 | $61.55B | +96.9% |
| Q3 FY2020 | Sep 30, 2020 | $11.41B | – |
| Q2 FY2020 | Jun 30, 2020 | $11.41B | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | $31.26B | – |
See a number that looks wrong?